These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 33140243)
41. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response. Souchelnytskyi S; Nera A; Souchelnytskyi N Sci Rep; 2021 Mar; 11(1):5228. PubMed ID: 33664395 [TBL] [Abstract][Full Text] [Related]
42. Pulmonary vasculature in COVID-19: mechanism to monitoring! Magoon R Korean J Anesthesiol; 2021 Apr; 74(2):186-187. PubMed ID: 33012159 [No Abstract] [Full Text] [Related]
43. Restoring the endothelial barrier function in the elderly. Barabutis N; Akhter MS; Kubra KT; Uddin MA Mech Ageing Dev; 2021 Jun; 196():111479. PubMed ID: 33819492 [TBL] [Abstract][Full Text] [Related]
44. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem. Mishra R; Florez-Perdomo WA; Vasquez HE; Moscote-Salazar LR; Agrawal A J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):767-768. PubMed ID: 32773261 [No Abstract] [Full Text] [Related]
45. Persistent SARS-CoV-2 infection in asymptomatic young adults. Ma MJ; Qiu SF; Cui XM; Ni M; Liu HJ; Ye RZ; Yao L; Liu HB; Cao WC; Song HB Signal Transduct Target Ther; 2022 Mar; 7(1):77. PubMed ID: 35264553 [No Abstract] [Full Text] [Related]
46. COVID-19-associated oxidative damage to red blood cells. Khakwani M; Horgan C; Ewing J Br J Haematol; 2021 May; 193(3):481. PubMed ID: 33427300 [No Abstract] [Full Text] [Related]
47. COVID-19: the difference between the nose and the lung. Gelardi M; Notargiacomo M; Trecca EMC; Cassano M; Ciprandi G Monaldi Arch Chest Dis; 2021 Mar; 91(2):. PubMed ID: 33666069 [TBL] [Abstract][Full Text] [Related]
49. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Caronna E; Ballvé A; Llauradó A; Gallardo VJ; Ariton DM; Lallana S; López Maza S; Olivé Gadea M; Quibus L; Restrepo JL; Rodrigo-Gisbert M; Vilaseca A; Hernandez Gonzalez M; Martinez Gallo M; Alpuente A; Torres-Ferrus M; Pujol Borrell R; Alvarez-Sabin J; Pozo-Rosich P Cephalalgia; 2020 Nov; 40(13):1410-1421. PubMed ID: 33146036 [TBL] [Abstract][Full Text] [Related]
50. An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays. Orooji Y; Sohrabi H; Hemmat N; Oroojalian F; Baradaran B; Mokhtarzadeh A; Mohaghegh M; Karimi-Maleh H Nanomicro Lett; 2021; 13(1):18. PubMed ID: 33163530 [TBL] [Abstract][Full Text] [Related]
51. Experimental and numerical study on the transport of droplet aerosols generated by occupants in a fever clinic. Zhou Y; Ji S Build Environ; 2021 Jan; 187():107402. PubMed ID: 33162646 [TBL] [Abstract][Full Text] [Related]
52. Intracranial Hemorrhage in Hospitalized SARS-CoV-2 Patients: A Case Series. Mousa-Ibrahim F; Berg S; Od TPDetola O; Teitcher M; Ruland S J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105428. PubMed ID: 33161349 [TBL] [Abstract][Full Text] [Related]
53. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression. Shen Z; Zhang G; Yang Y; Li M; Yang S; Peng G J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33151142 [TBL] [Abstract][Full Text] [Related]
54. Early Spread of SARS-CoV-2 in the Icelandic Population. Reply. Gudbjartsson DF; Stefansson K N Engl J Med; 2020 Nov; 383(22):2184-2185. PubMed ID: 33147384 [No Abstract] [Full Text] [Related]
55. Early Spread of SARS-CoV-2 in the Icelandic Population. Cowie BC; MacLachlan JH N Engl J Med; 2020 Nov; 383(22):2184. PubMed ID: 33147383 [No Abstract] [Full Text] [Related]
56. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons. Jafarzadeh A; Nemati M; Saha B; Bansode YD; Jafarzadeh S Viral Immunol; 2021 Jun; 34(5):307-320. PubMed ID: 33147113 [TBL] [Abstract][Full Text] [Related]
57. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19. Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564 [TBL] [Abstract][Full Text] [Related]
58. Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis. Tleyjeh IM; Kashour Z; AlDosary O; Riaz M; Tlayjeh H; Garbati MA; Tleyjeh R; Al-Mallah MH; Sohail MR; Gerberi D; Bin Abdulhak AA; Giudicessi JR; Ackerman MJ; Kashour T Mayo Clin Proc Innov Qual Outcomes; 2021 Feb; 5(1):137-150. PubMed ID: 33163895 [TBL] [Abstract][Full Text] [Related]
59. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data. Mallett S; Allen AJ; Graziadio S; Taylor SA; Sakai NS; Green K; Suklan J; Hyde C; Shinkins B; Zhelev Z; Peters J; Turner PJ; Roberts NW; di Ruffano LF; Wolff R; Whiting P; Winter A; Bhatnagar G; Nicholson BD; Halligan S BMC Med; 2020 Nov; 18(1):346. PubMed ID: 33143712 [TBL] [Abstract][Full Text] [Related]